UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 188

Sortiert nach

Nafld and liver transplantation: current burden and expected challenges

Journal of hepatology, 2016-12, Vol.65 (6), p.1245-1257

2016

Volltextzugriff (PDF)

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

Digestive diseases and sciences, 2015-11, Vol.60 (11), p.3318-3328

2015

Volltextzugriff (PDF)

Declining liver graft quality threatens the future of liver transplantation in the United States

Liver transplantation, 2015-08, Vol.21 (8), p.1040-1050

2015

Volltextzugriff (PDF)

Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions

Clinical therapeutics, 2021-03, Vol.43 (3), p.500-517

2021

Volltextzugriff (PDF)

Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century

The American journal of gastroenterology, 2020-01, Vol.115 (1), p.79-87

2020

Volltextzugriff (PDF)

When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network

The American journal of gastroenterology, 2023-12, Vol.118 (12), p.2301-2304

2023

Volltextzugriff (PDF)

Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard

Digestive diseases and sciences, 2021-06, Vol.66 (6), p.1767-1769

2021

Volltextzugriff (PDF)

We Are What We Eat: Food as Medicine in Health and Disease

Clinical therapeutics, 2022-05, Vol.44 (5), p.642-643

Barritt, A. Sidney

2022

Volltextzugriff (PDF)

Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy

The American journal of gastroenterology, 2023-02, Vol.118 (2), p.284-293

2023

Volltextzugriff (PDF)

Tangible Resources for Multidisciplinary Treatment of Patients With Nonalcoholic Fatty Liver Disease

The American journal of gastroenterology, 2023-03, Vol.118 (3), p.389-393

2023

Volltextzugriff (PDF)

Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death

Liver transplantation, 2013-01, Vol.19 (1), p.59-68

2013

Volltextzugriff (PDF)

Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection

The Journal of pediatrics, 2019-04, Vol.207, p.90-96

2019

Volltextzugriff (PDF)

High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort

The American journal of gastroenterology, 2024-08, Vol.119 (8), p.1624-1627

2024

Volltextzugriff (PDF)

Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know

Alimentary pharmacology & therapeutics, 2022-04, Vol.55 (8), p.944-959

2022

Volltextzugriff (PDF)

Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis

Clinical gastroenterology and hepatology, 2022-10, Vol.20 (10), p.2405-2408.e3

2022

Volltextzugriff (PDF)

Individual State Hepatitis C Data Supports Expanding Screening Beyond Baby Boomers to All Adults

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.1850-1851.e2

2018

Volltextzugriff (PDF)

Low Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study

Journal of Alzheimer's disease, 2021-01, Vol.79 (4), p.1775

2021

Volltextzugriff (PDF)

Intestinal microbiota in liver disease

Baillière's best practice & research. Clinical gastroenterology, 2016-02, Vol.30 (1), p.133-142

2016

Volltextzugriff (PDF)

SARS-CoV-2 infection in patients with autoimmune hepatitis

Journal of hepatology, 2021-06, Vol.74 (6), p.1335-1343

2021

Volltextzugriff (PDF)

Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (6), p.1314-1323.e1

2012

Volltextzugriff (PDF)

Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease—Effective Intervention for a Select Few

Gastroenterology (New York, N.Y. 1943), 2021-12, Vol.161 (6), p.2063-2064

2021

Volltextzugriff (PDF)

Immunosuppression in Autoimmune Hepatitis: Is There an End Game?

The American journal of gastroenterology, 2020-04, Vol.115 (4), p.498-501

2020

Volltextzugriff (PDF)

In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge

PloS one, 2020-02, Vol.15 (2), p.e0229497-e0229497

2020

Volltextzugriff (PDF)

Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends

Clinical therapeutics, 2022-03, Vol.44 (3), p.e45-e57

2022

Volltextzugriff (PDF)

A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy

The American journal of gastroenterology, 2020-04, Vol.115 (4), p.625-628

2020

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Nafld and liver transplantation: current burden and expected challenges

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

Declining liver graft quality threatens the future of liver transplantation in the United States

Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions

Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century

When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network

Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard

We Are What We Eat: Food as Medicine in Health and Disease

Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy

Tangible Resources for Multidisciplinary Treatment of Patients With Nonalcoholic Fatty Liver Disease

Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death

Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection

High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort

Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know

Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis

Individual State Hepatitis C Data Supports Expanding Screening Beyond Baby Boomers to All Adults

Low Liver Enzymes and Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study

Intestinal microbiota in liver disease

SARS-CoV-2 infection in patients with autoimmune hepatitis

Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus

Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease—Effective Intervention for a Select Few

Immunosuppression in Autoimmune Hepatitis: Is There an End Game?

In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge

Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends

A Quality Improvement Initiative Results in Improved Rates of Timely Postvariceal Bleeding Surveillance Endoscopy

Suchergebnisse filtern